InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	5.16	11.08	6.57	8.91	6.18	7.36
Short-Term Investments	0.04	0.04	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	5.2	11.12	6.61	8.96	6.22	7.41
Cash Growth	10.17%	68.10%	-26.15%	43.96%	-16.03%	26.70%
Accounts Receivable	-	0.47	0.35	0.26	0.09	0.01
Inventory	-	0.96	1.24	1.62	2.49	-
Other Current Assets	1.69	0.32	0.48	0.5	0.8	0.96
Total Current Assets	6.89	12.87	8.69	11.33	9.6	8.38
Net Property, Plant & Equipment	0.64	0.99	1.25	0.72	0.9	0.33
Other Intangible Assets	1.5	1.62	1.78	1.95	2.11	1.06
Other Long-Term Assets	0.1	0.1	0.1	0.1	0.18	0.01
Total Assets	9.13	15.58	11.82	14.11	12.79	9.78
Accounts Payable	1.01	1.4	1.65	1.61	2.42	2.13
Current Portion of Leases	0.39	0.44	0.32	0.38	0.4	0.08
Other Current Liabilities	0.81	-	-	0.02	0.5	-
Total Current Liabilities	2.21	1.84	1.97	2	3.32	2.22
Long-Term Leases	0.03	0.31	0.64	0.02	0.39	0.19
Total Long-Term Liabilities	0.03	0.31	0.64	0.02	0.39	0.19
Total Liabilities	2.24	2.15	2.62	2.02	3.71	2.4
Common Stock	92.58	91.22	82.78	77.62	70.72	60.59
Additional Paid-in Capital	38.14	39.32	35.37	35.74	31.68	21.51
Accumulated Other Comprehensive Income	0.13	0.13	0.13	0.13	0.13	0.13
Retained Earnings	-123.96	-117.24	-109.08	-101.4	-93.45	-74.85
Shareholders' Equity	6.89	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	9.13	15.58	11.82	14.11	12.79	9.78
Total Debt	0.42	0.74	0.96	0.39	0.79	0.27
Net Cash (Debt)	4.78	10.38	5.65	8.57	5.43	7.14
Net Cash Growth	-53.94%	83.62%	-34.01%	57.80%	-23.98%	29.08%
Net Cash Per Share	1.42	10.63	14.83	69.96	193.57	531.25
Book Value	6.89	13.43	9.21	12.09	9.08	7.38
Book Value Per Share	2.05	13.77	24.16	98.75	323.75	548.87
Tangible Book Value	5.39	11.81	7.42	10.14	6.97	6.31
Tangible Book Value Per Share	1.60	12.10	19.48	82.86	248.55	469.87

SEC Filings: 10-K · 10-Q